It is unclear what actions the Trump administration will take, if any, to protect the public against PFAS, linked to cancer and other health problems.

Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with ...

Company announced the launch of a full-scale product trial with NTT Data and a regional engineering firm, Hibiya Engineering, ...

Opteon™ 2P50, Chemours’ developmental dielectric thermal management fluid, has an ultra-low global warming potential of 10 ...

Per- and Polyfluoroalkyl Substances, more commonly known as PFAS, pose a danger to the health of our community. They have ...

The N.C. Department of Environmental Quality is continuing Chemours’ search for groundwater contamination beyond the Lower ...

The expansion comes after NCDEQ completed a review of residential well data around the Fayetteville Works plant.

Barclays analyst Michael Leithead maintained a Hold rating on Chemours Company (CC – Research Report) today and set a price target of $19.00.

Chemours ( NYSE: CC) is preparing to appoint the chief executive of Vision One Management Partners to its board in an effort ...

Chemours Co. plans to add the chief executive officer of Vision One Management Partners to its board as it seeks to avoid a ...

Critics say the bill would allow more pollution by making it easier to reclassify the state’s waterways. Proponents say it’s ...

Bank of New York Mellon Corp decreased its position in shares of The Chemours Company (NYSE:CC – Free Report) by 29.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The ...